Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2611789 | 0.88 | HSD11B1 (0.31) | HSD11B1 | |
| SCHEMBL12197284 | 0.85 | ALDH1A1 (0.33) | HSD11B1 | |
| SCHEMBL26939202 | 0.84 | HSD11B1 (0.35) | HSD11B1 | |
| SCHEMBL25509618 | 0.83 | HSD11B1 (0.35) | HSD11B1 | |
| SCHEMBL439022 | 0.83 | HSD11B1 (0.32) | HSD11B1 | |
| SCHEMBL19565069 | 0.82 | — | — | |
| SCHEMBL4903389 | 0.81 | HSD11B1 (0.31) | HSD11B1 | |
| SCHEMBL14839298 | 0.81 | HSD11B1 (0.31) | HSD11B1 | |
| SCHEMBL7079582 | 0.81 | ALDH1A1 (0.40) | HSD11B1 | |
| SCHEMBL5161826 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6500971-B2 | Ester compounds having alicyclic and oxirane structures and method for preparing the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-12-31 | — | — | US | disclosed |
| US-20020035279-A1 | Novel ester compounds having alicyclic and oxirane structures and method for preparing the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035279-A1 | Novel ester compounds having alicyclic and oxirane structures and method for preparing the same | OXER1, OXGR1, ITGA1 | HSD11B1 1085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.